New program seeks FDA authorization for fieldable blood analog system in 2029.
RAPIIDly transitioning shelf-stable blood substitutes to the battlefield
calendar_today
May 28, 2026
person
outreach@darpa.mil
domain
defense-advanced-research-projects-agency